VCEL
Vericel Corporation
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
42.68
▲ 0.57 (1.35%)
MARKET · —
Price
Open
42.24
Prev close
42.11
Day high
42.85
Day low
41.76
Volume
576.61K
Market cap
$2.19B
P/E (TTM)
88.92
52W range
28.95 – 49.32
Trailing performance
Returnvs SPY
1W
-3.44%
-2.1%
1M
-5.26%
-9.0%
3M
+21.42%
+18.3%
6M
+12.05%
+1.0%
YTD
+18.52%
+6.2%
1Y
+20.70%
+0.7%
3Y
+32.46%
-41.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$2.19B
Enterprise value$2.12B
Revenue (TTM)$306.30M
Gross profit$228.38M
EBITDA$31.15M
Net income$24.22M
EPS (TTM)$0.48
Free cash flow$55.54M
Total cash$162.46M
Total debt$93.13M
Book value / share$7.23
Shares outstanding51.21M
Float50.58M
Short % of float11.15%
Dividend yield—
Beta (5Y)1.07
Valuation & profitability ratios
Trailing P/E88.92
Forward P/E50.45
PEG ratio—
Price / sales—
Price / book5.90
EV / revenue6.91
EV / EBITDA67.93
Gross margin74.56%
Operating margin0.56%
Profit margin7.91%
Return on equity7.16%
Return on assets2.43%
Debt / equity25.17
Current ratio5.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $276.26M | $237.22M | $197.52M | $164.37M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $16.52M | $10.36M | -$3.18M | -$16.71M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $16.52M | $10.36M | -$3.18M | -$16.71M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.03 | 0.04 | +250.0% |
| Mar 2026 | -0.16 | -0.12 | +23.4% |
| Dec 2025 | 0.38 | 0.45 | +17.8% |
| Sep 2025 | -0.01 | 0.10 | +850.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 5 | $77.95M | +15.5% |
| Next quarter | 0.53 | 5 | $112.40M | +21.0% |
| Current year | 0.52 | 5 | $336.22M | +21.7% |
| Next year | 0.85 | 5 | $392.91M | +16.9% |
Analyst targets & ownership
Mean target$60.57
High target$72.00
Low target$55.00
Implied upside41.92%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy0 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders1.19%
Held by institutions111.13%
Institutions holding427
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+65.05K
Net buying
Buy transactions
26
225.71K shares
Sell transactions
18
160.66K shares
Net transactions
+44
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
609.36K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | MCLAUGHLIN KEVIN F Director |
CONVERSION | 7.00K | $91.35K | Direct |
| Aug 12, 26 | MCLAUGHLIN KEVIN F Director |
SELL | 7.00K | $311.71K | Direct |
| Aug 3, 26 | HALPIN MICHAEL Chief Operating Officer |
CONVERSION | 10.00K | $166.60K | Direct |
| Aug 3, 26 | HALPIN MICHAEL Chief Operating Officer |
SELL | 10.00K | $468.40K | Direct |
| Jul 30, 26 | SIEGAL JONATHAN D. Officer |
CONVERSION | 4.50K | $141.81K | Direct |
| Jul 30, 26 | SIEGAL JONATHAN D. Officer |
SELL | 4.50K | $220.05K | Direct |
| Jun 26, 26 | HOPPER JONATHAN MARK Officer |
CONVERSION | 10.00K | $298.20K | Direct |
| Jun 26, 26 | FLYNN SEAN C Officer |
CONVERSION | 15.00K | $243.75K | Direct |
| Jun 26, 26 | SIEGAL JONATHAN D. Officer |
CONVERSION | 2.50K | $74.55K | Direct |
| Jun 26, 26 | FLYNN SEAN C Officer |
SELL | 15.00K | $684.60K | Direct |
| Jun 26, 26 | MARA JOSEPH ANTHONY JR Chief Financial Officer |
SELL | 5.00K | $223.75K | Direct |
| Jun 26, 26 | SIEGAL JONATHAN D. Officer |
SELL | 2.73K | $122.67K | Direct |
| Jun 26, 26 | HOPPER JONATHAN MARK Officer |
SELL | 10.00K | $450.00K | Direct |
| Jun 18, 26 | HALPIN MICHAEL Chief Operating Officer |
CONVERSION | 10.00K | $166.60K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COLANGELO DOMINICK C |
Chief Executive Officer | 312.45K | Conversion of Exercise of derivative security |
HAGEN HEIDI M. |
Director | 35.05K | Conversion of Exercise of derivative security |
HALPIN MICHAEL |
Chief Operating Officer | 16.39K | Conversion of Exercise of derivative security |
HOPPER JONATHAN MARK |
Officer | 75.75K | Conversion of Exercise of derivative security |
MARA JOSEPH ANTHONY JR |
Chief Financial Officer | 16.01K | Sale |
MCLAUGHLIN KEVIN F |
Director | 18.30K | Conversion of Exercise of derivative security |
RUBINO ALAN L |
Director | 64.19K | Conversion of Exercise of derivative security |
WOTTON PAUL K |
Director | 18.80K | Sale |
WRIGHT LISA |
Director | 15.85K | Conversion of Exercise of derivative security |
ZERBE ROBERT L |
Director | 32.99K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
43.80
-2.55% from price
SMA 20
44.89
-4.92% from price
SMA 50
44.41
-3.89% from price
SMA 100
39.52
+8.00% from price
SMA 200
38.05
+12.18% from price
EMA 12
43.91
-2.81% from price
EMA 26
44.36
-3.78% from price
EMA 50
43.37
-1.58% from price
RSI (14)
40.8
Neutral
MACD (12,26,9)
-0.45
Hist -0.40
ATR (14)
1.58
3.71% of price
Realised vol 30D
28.9%
Annualised
Bollinger upper
47.61
20, 2σ
Bollinger lower
42.17
20, 2σ
50 / 200 cross
Golden
44.41 vs 38.05
Trend bias
Above 200
+12.18%
Risk profile
Beta vs SPY
0.93
Less volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
28.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-31.0%
Peak to trough
Max drawdown 5Y
-70.5%
Peak to trough
ATR 14
1.58
3.71% of price
Beta (reported)
1.07
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.08
Call-heavy session
Put / call open interest
0.15
Positioning, not flow
Max pain
45.00
+5.4% from spot
ATM implied vol
74.3%
Nearest strike to spot
Skew (10% OTM)
+7.8%
Puts bid over calls
Call volume
13
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
55.00
13 contracts
Heaviest put OI
40.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
MediWound Q2 Earnings Call Highlights
MarketBeat · 9d ago
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · 9d ago
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
IPO-Edge.com · 19d ago
Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating
MT Newswires · 22d ago
Vericel Q2 Earnings Call Highlights
MarketBeat · 23d ago
Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates
Zacks · 23d ago
Vericel Swings to Q2 Net Income, Revenue Rises; Full-Year 2026 Revenue Guidance Raised
MT Newswires · 23d ago
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
GlobeNewswire · 23d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.